(S)-Atenolol-d7

(S)-Atenolol-d7 is a deuterated form of the commonly used beta-blocker medication, Atenolol. Atenolol is primarily used to treat hypertension, angina, and various cardiovascular conditions. The addition of deuterium to Atenolol in (S)-Atenolol-d7 provides a unique tool for researchers to study the pharmacokinetics and metabolic pathways of the drug in vivo. The deuterium atoms in (S)-Atenolol-d7 replace seven of the hydrogen atoms in Atenolol. This modification alters the vibrational frequencies of the chemical bonds within the molecule, resulting in a distinctive isotopic fingerprint that can be traced and measured using analytical techniques like mass spectrometry. This enables researchers to accurately quantify the concentration of (S)-Atenolol-d7 in biological samples, as well as track its metabolic fate and interactions with other drugs or metabolic pathways. (S)-Atenolol-d7 is a valuable tool for studying the pharmacokinetics and pharmacodynamics of Atenolol in vivo. It can be used for a range of applications, from basic research into drug metabolism and pharmacology, to clinical studies evaluating the efficacy and safety of Atenolol in patients. The deuterium label in (S)-Atenolol-d7 provides researchers with a powerful analytical tool for understanding the complex mechanisms underlying the action and metabolism of this important medication.